Wolverine Trading
MDCO

Wolverine Trading’s Medicines Co MDCO Stock Holding History

Wolverine Trading’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-111,000
Closed -$9.42M – 5700
2019
Q4 		$9.42M Buy
111,000
+58,700
+112% +$3.91M 0.02% 703
2019
Q3 		$2.52M Buy
+52,300
New +$2.09M 0.01% 1276
2019
Q2 		– Sell
-63,100
Closed -$1.76M – 5480
2019
Q1 		$1.76M Sell
63,100
-7,600
-11% -$179K 0.01% 1634
2018
Q4 		$1.34M Buy
70,700
+34,400
+95% +$800K ﹤0.01% 1737
2018
Q3 		$1.09M Buy
36,300
+100
+0.3% +$3.77K ﹤0.01% 2266
2018
Q2 		$1.19M Hold
36,200
– – ﹤0.01% 2073
2018
Q1 		$1.19M Buy
36,200
+20,800
+135% +$650K ﹤0.01% 2073
2017
Q4 		$421K Buy
15,400
+1,600
+12% +$49.3K ﹤0.01% 3212
2017
Q3 		$511K Sell
13,800
-11,100
-45% -$409K ﹤0.01% 2579
2017
Q2 		$966K Sell
24,900
-20,400
-45% -$909K ﹤0.01% 1771
2017
Q1 		$2.22M Buy
45,300
+11,300
+33% +$515K 0.01% 1119
2016
Q4 		$1.15M Sell
34,000
-16,700
-33% -$592K 0.01% 1781
2016
Q3 		$1.93M Buy
50,700
+34,600
+215% +$1.3M 0.01% 1328
2016
Q2 		$544K Buy
+16,100
New +$568K ﹤0.01% 2153

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wolverine Trading's MDCO Position: Q1 2020 in Review

Wolverine Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 50,660 shares — an estimated $4.3M sold.

Wolverine Trading first reported a position in MDCO in Q2 2016 and held it in 9 quarters. The position peaked at $4.3M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Wolverine Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 50,660 Medicines Co shares in Q1 2020, an estimated $4.3M.
  • Wolverine Trading first reported a position in Medicines Co in Q2 2016 and held it in 9 quarters.
  • Wolverine Trading's Medicines Co position peaked at $4.3M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.